The World Health Organization (WHO) has urged governments worldwide to step up the supervision of vaccine manufacture and distribution, especially when public funding is used in vaccine R&D or manufacture, so as to prioritise essential vaccines and ensure they are distributed equitably.  The global health agency’s call to governments came as it released its annual […] Continue reading ->
The World Health Organization (WHO) has raised the alarm over drug-resistant fungi as it released its first-ever priority list of fungal pathogens at risk from antimicrobial resistance (AMR). Nineteen species of fungi have been identified by the global health agency as representing “the greatest threat to public health” due to their growing drug resistance.   Meanwhile, […] Continue reading ->
A precedent-setting agreement to permit an expensive cancer drug to be produced more affordably by generic manufacturers has been signed between the Medicines Patent Pool (MPP) and pharmaceutical company Novartis, enabling much wider access to a medicine that treats a rare blood cancer. Nilotinib is a twice-daily oral medication used to treat chronic myeloid leukaemia […] Continue reading ->